HYTERRA LTD — AGM Information 2007

Aug 30, 2007

==> picture [38 x 38] intentionally omitted <==

BrainZ Instruments Limited 2007 Annual Shareholders Meeting Chairman’s Address – Mike Smith

www.brainz.com

© 2007 BrainZ Instruments Limited

BrainZ FY 2007 highlights

• 163% Increase in Unit Sales over prior same time period

• 42% Increase of Installed Base throughout 20 countries

• GE Healthcare Distribution Contract extended through to October 2008 and expanded geographical coverage into Asia

• Received CE Mark and CMDCAS certifications of seizuredetection product RecogniZe[™]

• Became the exclusive monitoring partner for NEOBRAIN – a major E-U funded research project a brain injury of the pre-term

• Awarded NZ$500,000 growth service grant

• © 2007 BrainZ Instruments Limited

www.brainz.com

==> picture [38 x 38] intentionally omitted <==

BrainZ Instruments Limited 2007 Annual Shareholders Meeting CEO’s Address – Richard Smith

www.brainz.com

© 2007 BrainZ Instruments Limited

Bedside Brain Monitoring – The Need

==> picture [721 x 464] intentionally omitted <==

----- Start of picture text -----

Traditional
EEG
Using 16
Channels
thru 21
15-30 Seconds of Data
Electrodes
BRM2
aEEG
Using 3
Channels
thru 4 3.5 hours aEEG Pattern
Electrodes
www.brainz.com
© 2007 BrainZ Instruments Limited
----- End of picture text -----

Bedside Brain Monitoring – The Market

• Positive Market Drivers

― Clinical Research is establishing the efficacy of a EEG for neonatal use ― Therapeutic interventions are being developed for neonatal bran injury (eg cooling)

― Traditional EEG companies are now targeting the bedside

• Market Challenges

― Lack of agreed therapeutic interventions clouds the clinical relevance debate

― US Specific

―Medico Legal – risks associated with enhanced insights ―FDA’s changing view on diagnostic tools at the bedside

www.brainz.com

© 2007 BrainZ Instruments Limited

Bedside Brain Monitoring – BrainZ Position

• Strengths

― The first company to focus at the bedside ― Global brand recognition with neonatal clinicians ― Relationships with Key Opinion Leaders ― Clinical Training program

― Core competence in algorithm knowledge and development

• Challenges

― Anticipating the evolving role of Neurologist

― The potential for more advanced tools at the bedside

www.brainz.com

© 2007 BrainZ Instruments Limited

BrainZ Distribution Model

==> picture [695 x 81] intentionally omitted <==

----- Start of picture text -----

Bedside
Brain
Clinicians
Monitoring
----- End of picture text -----

GE pushes BrainZ technology to clinicians through…	BrainZ pulls clinicians to its technology through…
Exhibiting BrainZ technology at every congress / convention	Support of research on clinical utility: • publications • speakers at conferences
Adding BrainZ to GE’s national account contracts	Direct marketing: • direct mail • telemarketing efforts • direct support on key opportunities
Adding BrainZ to GE’s major deals	Specialty conferences
Adding visibility on daily sales calls	Education: workshops and training events
Providing quotes and closing orders	Funnel management

© 2007 BrainZ Instruments Limited

BrainZ Market Activities During 2007

• BrainZ Direct Sponsorship of Major Congresses

― 10th International Child Neurology Congress ― The Newborn Brain from Foundations to New Frontiers ― Children's Neurology Society ― American Clinical Neurophysiology Society ― Hot Topics in Neonatology ― 2[nd] International Conference on Neonatal Brain Monitoring

• Supported GE Healthcare’s Global Congresses

― North America

― Support four national conferences and several local

― Europe

― Supported two major conferences

www.brainz.com

© 2007 BrainZ Instruments Limited

BrainZ Market Activities During 2007 (Con’t)

• Direct Mailers

• Conducted a direct mail campaign to all US Hospitals

• Sent to Neurology, Neonatology, Neonatal Nursing and the Purchasing Departments

• UK Office Opened

• 2 Staff Hired

• Support of GE Healthcare

• Traveled to and supported all major territory launches

• Made visits to key targets within these territories

• © 2007 BrainZ Instruments Limited

www.brainz.com

BrainZ FY2007 Financials (NZ$)

					7 Months March 2007		12 months August		2006
		Sales revenue			1,406		1,565
		Total revenue			1,959		4,656
		Earnings before tax*			(3,504)		(831)
		Non- recurringitems			-		(5,249)
		EBT			(3,504)		(6,080)
		Net earnings			(3,525)		(4,962)
		*excluding non-recurring items
									www.brainz.com
							© 2007 BrainZ Instruments Limited

BrainZ FY2007 Financials (NZ$)

	March 2007	August 2006
Cash	6,970	10,140
Total Current Assets	8,352	11,548
Non- Current Assets	5,079	5,440
Total Assets	13,431	16,988
Current Liabilities	584	616
Share Capital	25,623	25,623
Reserves	(12,776)	(9,251)
Equity and Liabilities	13,431	16,988

BrainZ FY2007 Financials (NZ$)

	7 months March 2007	12 months August 2006
Operating cash in	1,735	2,626
Operating cash out	(3,977)	(4,489)
Net Operating Cash	(2,242)	(1,863)
Net Investing Cash	(136)	(2,097)
Net Financing Cash	-	12,363
Net change in Cash	(2,378)	8,403
Foreign Exchange	(792)	1,559
Cash at End of Period	6,970	10,140

BrainZ FY2008 Q1 Achievements

• New Market Launches

• Italy; Spain; and the Middle East

• Major Congresses

― Paediatric Society of Australia and New Zealand (PSANZ) ―Key Opinion Leader conducted a major workshop an aEEG ― Pediatric Academic Societies (PAS) Meeting ―16 abstracts on aEEG were presented ―BrainZ hosted a networking session for 40 Key Opinion Leader ― World Congress of Pediatric Intensive Care ―Brain Sponsored two major sessions on Neonatal and Pediatric Utility ―Two independent sessions were presented on Pediatric Utility

www.brainz.com

© 2007 BrainZ Instruments Limited

BrainZ FY2008 Q1 Achievements

• New Customer Acquisition

• Customer Installs increased approximately 40% over prior year’s period ― Pipeline continues to grow globally

― Developing a “World Class CRM System” ― We have now begun to close orders without “evaluations.”

• GE Healthcare Relationship

― New joint programs targeting market development & sales activity ― Standing meetings with Upstream (product) and Downstream (commercial) teams

© 2007 BrainZ Instruments Limited

www.brainz.com

BrainZ FY2008 Current

• New Platform BRM3

• Enhanced printer options and mounting capability – addresses customers’ practical utility requirements

― Summary printouts for patient records – addresses the medico-legal requirements of some customers

― Improved computing performance

• USB 2.0 compatibility – improves integration with customers’ management systems

― Redesigned Data Acquisition Unit

― Built-in future capabilities – anticipating additional data requirements

• Launch

• Europe & Middle East in September

― North America pending 510K clearance

www.brainz.com

© 2007 BrainZ Instruments Limited

BRM3 Brain Monitor

==> picture [159 x 262] intentionally omitted <==

Monitor

• New design – better usability

• New Stand – Improved Quality

• • Enhanced features

==> picture [251 x 167] intentionally omitted <==

Printer Capabilities

• Provides one solution for patient record requirements

• Compatible with multiple color printer models

==> picture [155 x 262] intentionally omitted <==

• Data Acquisition Unit

• New design – more compact

• Strap with connected test plug – usability benefits

• • Built-in future capabilities

www.brainz.com

© 2007 BrainZ Instruments Limited

BrainZ FY2008 Future

• Operational targets

• Improve cash flow

― Transition from early development to commercially focused processes ― Optimize relationship with GE Healthcare

• Product Development

• Focus on product enhancements which

  • ―Improve application time ―Improve clinical utility

• Clinical Support

• Develop more efficient training programs

www.brainz.com

© 2007 BrainZ Instruments Limited

==> picture [38 x 38] intentionally omitted <==

BrainZ Instruments Limited 2007 Annual Shareholders Meeting Questions

www.brainz.com

© 2007 BrainZ Instruments Limited